Skin adnexal neoplasms - Part 1: An approach to tumours of the pilosebaceous unit

Journal of Clinical Pathology

Volumn 60, Issue 2, 2007, Pages 129-144

  Alsaad, K O ^b   Obaidat, N A ^b   Ghazarian, D ^a,b  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADNEXA DISEASE; BASAL CELL CARCINOMA; DIFFERENTIAL DIAGNOSIS; HISTOPATHOLOGY; HUMAN; PILOMATRIXOMA; PRIORITY JOURNAL; REVIEW; SEBACEOUS CARCINOMA; SEBACEOUS NEVUS; SKIN ADNEXAL NEOPLASM; SKIN APPENDAGE; SKIN BIOPSY; SKIN DEFECT; SKIN TUMOR; TRICHILEMMOMA; TRICHOBLASTOMA; TRICHOEPITHELIOMA; TUBEROUS SCLEROSIS;

HUMANS; NEOPLASMS, ADNEXAL AND SKIN APPENDAGE; NEOPLASMS, BASAL CELL; SEBACEOUS GLAND NEOPLASMS; SKIN; SKIN NEOPLASMS;

EID: 33847001622     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2006.040337     Document Type: Review

References (80)

1. Rudolph P. Benign adnexal skin tumors. Pathologe 2002;23:71-8.
2. Rodriguez-Diaz E, Armio M. Mixed tumors with follicular differentiation: complex neoplasms of the primary epithelial germ. Int J Dermatol 1995;34:782-5.
3. Sato K, Kang WH, Saga K, et al. Biology of sweat glands and their disorders. I. Normal sweat gland function. J Am Acad Dermatol 1989;20:537-63.
4. van der Putte SC. Apoeccrine glands in nevus sebaceous. Am J Dermatopathol 1994;16:23-30.
5. Klein W, Chan E, Seykora JT. Tumors of the epidermal appendages. In: Elder DE, Editor-in-Chief. Lever's histopathology of the skin. 9th edn. Philadelphia, PA: Lippincott Williams & Wilikins, 2005:867-926.
6. Kamada A, Saga K, Jimbow K. Apoeccrine sweat duct obstruction as a cause for Fox-Fordyce disease. J Am Acad Dermatol 2003;48:453-5.
7. Wheeler CE Jr, Carroll MA, Groben PA, et al. Autosomal dominantly inherited generalized basaloid follicular hamartoma syndrome: report of a new disease in a North Carolina family. J Am Dermatol 2000;43:189-206.
8. Yoshida Y, Urabe K, Mashino T, et al. Basal cell carcinomas in association with basaloid follicular hamartoma. Dermatology 2003;207:57-60.
9. Akasaka T, Kon S, Mihm MC Jr. Multiple basaloid cell hamartoma with alopecia and autoimmune disease (systemic lupus erythematosus). J Dermatol 1996;23:821-4.
10. Morton S, Stevens A, Powell RJ. Basaloid follicular hamartoma, total body hair loss and SLE. Lupus 1998;3:207-9.
11. Mascaro JM Jr, Ferrando J, Bombi JA, et al. Congenital generalized follicular hamartoma associated with alopecia and cystic fibrosis in three siblings. Arch Dermatol 1995;131:454-8.
12. Jih DM, Shapiro M, James WD, et al. Familial basaloid follicular hamartoma: lesional characterization and review of the literature. Am J Dermatopathol 2003;25:130-7.
13. Stashower ME, Smith K, Corbett D, et al. Basaloid/follicular hyperplasia overlying connective tissue/mesenchymal hamartomas simulating basal cell carcinomas. J Am Acad Dermatol 2001;45:886-91.
14. Mehregan DR, Thomas L, Thomas JE. Epidermal basaloid proliferation in cutaneous myxomas. J Cutan Pathol 2003;30:499-503.
15. Han KH, Huh CH, Cho KH. Proliferation and differentiation of the keratinocytes in hyperplastic epidermis overlying dermatofibroma: immunohistochemical characterization. Am J Dermatopathol 2001;23:90-8.
16. Rossen K, Haersley T, Hou-Jensen K, et al. Metallothionein expression in basaloid proliferations overlying dermatofibromas and in basal cell carcinomas. Br J Dermatol 1997;136:30-4.
17. Rossen K, Haersley T, Hou-Jensen K, et al. Bcl-2 overexpression in basaloid proliferations overlying dermatofibromas and basal cell carcinomas. APMIS 1997;105:35-40.
18. Haersley T, Rossen K, Hou-Jensen K, et al. Immunohistochemical detection of p53 in epidermal proliferations overlying dermatofibromas. Acta Dermatol Venereol 1995;75:187-9.
19. Mahmoodi M, Asad H, Salim S, et al. Anti-cytokeratyin 20 staining of Merkel cells helps differentiate basaloid proliferations overlying dermatofibromas from basal cell carcinoma. J Cutan Pathol 2005;32:491-5.
20. Hartschuh W, Schulz T. Immunohistochemical investigation of the different developmental stages of trichofolliculoma with special reference to the Merkel cell. Am J Dermatopathol 1999;21:8-15.
21. Stem JB, Stout DA. Trichofolliculoma showing perineural invasion. Trichofolliculocarcinoma? Arch Dermatol 1979;115:1003-4.
22. Plewig G. Sebaceous trichofolliculoma. J Cutan Pathol 1980;7:394-403.
23. Ramdial PK, Chrystal V, Madaree A. Folliculosebaceous cystic hamartoma. Pathology 1998;30:212-14.
24. Tanimura S, Arita K, Iwao F, et al. Two cases of folliculosebaceous cystic hamartoma. Clin Exp Dermatol 2006;31:68-70.
25. Welsch MJ, Krunic A, Medenica MM. Birt-Hogg-Dube syndrome. Int J Dermatol 2005;44:668-73.
26. Harada H, Hashimoto K, Ko MS. The gene for multiple familial trichoepithelioma maps to chromosome 9p21. J Invest Dermatol 1996;107:41-3.
27. Zhang XJ, Liang YH, He PP, et al. Identification of the cylindromatosis tumor-suppressor gene responsible for multiple familial trichoepithelioma. J Invest Dermatol 2004;122:658-64.
28. Zheng G, Hu L, Huang W, et al. CYLD mutation causes multiple familial trichoepithelioma in three Chinese families. Hum Mutat 2004;23:400.
29. Kanitakis J, Bourchany D, Faure M, et al. Expression of the hair stem cell-specific keratin 15 in pilar tumours of skin. Eur J Dermatol 1999;9:363-5.
30. Yamamoto O, Asahi M. Cytokeratin expression in trichoblastic fibroma (small nodular type trichoblastoma), trichoepithelioma and basal cell carcinoma. Br J Dermatol 1999;140:8-16.
31. Poniecka AW, Alexis JB. An immunohistochemical study of basal cell carcinoma and trichoepithelioma. Am J Dermatopathol 199, 21:332-6.
32. Kirchmann TT, Prieto VG, Smoller BR. Use of CD34 in assessing the relationship between stroma and tumor in desmoplastic keratinocytic neoplasms. J Cutan Pathol 1995;22:422-6.
33. Pham TT, Selim MA, Burchette JL Jr, et al. CD10 expression in trichoepithelioma and basal cell carcinoma. J Cutan Pathol 2006;33:123-8.
34. Abdelsayed RA, Guijarro-Rojas M, Ibrahim NA, et al. Immunohistochemical evaluation of basal cell carcinoma and trichoepithelioma using bcl-2, Ki67, PCNA and p53. J Cutan Pathol 2000;27:169-75.
35. Hunt SJ, Abell E. Malignant hair matrix tumor ("malignant trichoepithelioma") arising in the setting of multiple hereditary trichoepithelioma. Am J Dermatopathol 1991;13:275-81.
36. Matsuki T, Hayashi N, Mizushima J, et al. Two cases of desmoplastic trichoepithelioma. J Dermatol 2004;31:824-7.
37. Takei Y, Fukushiro S, Ackerman AB. Criteria for histologic differentiation of desmoplastic trichoepithelioma (sclerosing epithelial hamartoma) from morphea-like basal-cell carcinoma. Am J Dermatopathol 1985;7:207-21.
38. Kirchmann TT, Prieto VG, Smoller BR. CD34 staining pattern distinguishes basal cell carcinoma from trichoepithelioma. Arch Dermatol 1994;130:589-92.
39. Thewes M, Worret WI, Engst R, et al. Stromelysin-3: a potent marker for histologic differentiation between desmoplastic trichoepithelioma and morphealike basal cell carcinoma. Am J Dermatopathol 1998;20:140-2.
40. Abesamis-Cubillan E, El-Shabrawi-Caelen L, LeBoit PE. Merkel cells and sclerosing epithelial neoplasms. Am J Dermatopathol 2000;22:311-15.
41. Jaqueti G, Requena L, Sanchez Yus E. Trichoblastoma is the most common neoplasm develop in nevus sebaceous of Jadassohn: a clinicopathologic study of a series of 155 cases. Am J Dermatopathol 2000;22:108-18.
42. Cribier B, Scrivener Y, Grosshans E. Tumors arising in nevus sebaceous: a study of 596 cases. J Am Acad Dermatol 2000;42:263-8.
43. Beguin L, Poulin JF, Chatelanin D, et al. Plaque variant of trichoblastic fibroma. Ann Dermatol Venereol 2001;128:35-7.
44. Altman DA, Mikhail GR, Johnson TM, et al. Trichoblastic fibroma. A series of 10 cases with report of a new plaque variant. Arch Dermatol 1995;131:198-201.
45. Regauer S, Beham-Schmid C, Okuc M, et al. Trichoblastic carcinoma ("malignant trichoblastoma") with lymphatic and hematogenous metastases. Mod Pathol 2000;13:673-8.
46. Schulz T, Proske S, Hartschuh W, et al. High-grade trichoblastic carcinoma arising in trichoblastoma: a rare adnexal neoplasm often showing metastatic spread. Am J Dermatopathol 2005;27:9-16.
47. Brownstein MH, Mehregan AH, Bikowski JB, et al. The dermatopathology of Coweden's syndrome. Br J Dermatol 1979;100:667-73.
48. Hunt SJ, Kilzer B, Santa Cruz DJ. Desmoplastic trichilemmoma: histologic variant resembling invasive carcinoma. J Cutan Pathol 1990;17:45-52.
49. Tellechea O, Reis JP, Baptista AP. Desmoplastic trichilemmoma. Am J Derrmatopathol 1992;14:107-4.
50. Illueca C, Monteagudo C, Revert A, et al. Diagnostic value of CD34 immunostaining in desmoplastic trichilemmoma. J Cutan Pathol 1998;25:435-9.
51. Chan KO, Kim IJ, Baladas HG, et al. Multiple tumour presentation of trichilemmal carcinoma. Dermatol Surg 2003;29:886-9.
52. Lai TF, Huilgol SC, James CL, et al. Trichilemmal carcinoma of the upper eyelid. Acta Opthalmol Scand 2003;81:536-8.
53. Casas JG, Woscoff A. Giant pilar tumor of the scalp. Arch Dermatol 1980;116:1395.
54. Bengoechea-Beeby MP, Velasco-Oses A, Casado-Perez C. Multiple proliferating trichilemmal tumors and cysts involving the scalp: report of a case. J Oral Maxillofac Surg 1994;52:985-6.
55. Folpe AL, Reisenauer AK, Mentzel T, et al. Proliferating trichilemmal tumors: clinicopathologic evaluation is a guide to biologic behavior. J Cutan Pathol 2003;30:492-8.
56. Lopez-Rios F, Rodriguez-Peralto JL, Aguilar A, et al. Proliferating trichilemmal cyst with focal invasion: report of a case and a review of the literature. Am J Dermatopathol 2000;22:183-7.
57. Fernandez SH. Malignant proliferating trichilemmal tumour: a case report. Malays J Pathol 1999;21:117-21.
58. Amoral AL, Nascimento AG, Goellner JR. Proliferating pilar (trichilemmal) cyst. Report of two cases, one with carcinomatous transformation and one with distant metastases. Arch Pathol Lab Med 1984;108:808- 10.
59. Geh JL, Moss AL. Multiple pilomatrixomata and myotonic dystrophy: a familial association. Br J Plast Surg 1999;52:143-5.
60. Boyle P, Bazex J, Lamant L, et al. Multiple perforating and non perforating pilomatricomas in a patient with Churg-Strauss syndrome and Rubinstein-Taybi syndrome. J Eur Acad Dermatol Venereol 2004;18:607-10.
61. Noguchi H, Kayashima K, Nishiyama S, et al. Two cases of pilomatrixoma in Turner's syndrome. Dermatology 1999;199:338-40.
62. Xia J, Urabe K, Moroi Y, et al. beta-Catenin mutation and its nuclear localization are confirmed to be frequent causes of Wnt signaling pathway activation in pilomatricomas. J Dermatol Sci 2006;41:67- 75.
63. Folk S. EMH in pilomatricomas. Am J Dermatopathol 1996;18:218-19.
64. Bremnes RM, Kvamme JM, Stalsberg H, et al. Pilomatrix carcinoma with multiple metastases: report of a case and review of the literature. Eur J Cancer 1999;35:433-7.
65. Bassarova A, Nesland JM, Sedloev T, et al. Pilomatrix carcinoma with lymph node metastases. J Cutan Pathol 2004;31:330- 5.
66. Ponti G, Ponz de Leon M. Muir-Torr syndrome. Lancet Oncol 2005;6:980-7.
67. Misago N, Suse T, Uemura T, et al. Basal cell carcinoma with sebaceous differentiation. Am J Dermatopathol 2004;26:298- 303.
68. Misogo N, Mihara I, Ansai S, et al. Sebaceoma and related neoplasms with sebaceous differentiation: a clinicopathologic study of 30 cases. Am J Dermatopathol 2002;24:294-304.
69. Pereira PR, Odashiro AN, Rodrigues-Reyes AA, et al. Histopathological review of sebaceous carcinoma of the eyelid. J Cutan Pathol 2005;32:496-501.
70. Ansai S, Mitsuhashi Y, Kondo S, et al. Immunohistochemical differentiation of extra-ocular sebaceous carcinoma from other skin cancers. J Dermatol 2004;31:998-1008.
71. Bayer-Garner IB, Givens V, Smaller B. Immunohistochemical staining for androgen receptors: a sensitive marker of sebaceous differentiation. Am J Dermatopathol 1999;21:426-31.
72. Schirren CG, Jansen T, Lindner A, et al. Diffuse sebaceous gland hyperplasia. A case report and an immunohistochemical study with cytokeratins. Am J Dermatopathol 1996;18:296-301.
73. Sugarman JL. Epidermal nevus syndromes. Semin Cutan Med Surg 2004;23:145-57.
74. Ball FA, Hussain M, Moss AL. Squamous cell carcinoma and basal cell carcinoma arising in a naevus sebaceous of Jadassohn: case report and literature review. Clin Exp Dermatol 2005;30:259-60.
75. Misago N, Narisaway Y. Tricholemmal carcinoma in continuity with trichoblastoma within nevus sebaceus. Am J Dermatopathol 2002;24:149-55.
76. de Giorgi V, Massi D, Brunasso G, et al. Sebaceous carcinoma arising from nevus seoaceus: a case report. Dermatol Surg 2003;29:105-7.
77. Tarkhan II, Domingo J. Metastasizing eccrine porocarcinoma developing in a sebaceous nevus of Jadassohn. Report of a case. Arch Dermatol 1985;121:413-15.
78. Dalles S, Skowron F, Balme B, et al. Apocrine carcinoma developed in nevus sebaceous of Jadassohn. Eur J Dermatol 2003;13:487-9.
79. Miller CJ, Ioffreda MD, Billingsley EM. Sebaceous carcinoma, basal cell carcinoma, trichoadenoma, trichoblastoma, and syringocystadenoma papilliferum arising within a nevus sebaceus. Dermatol Surg 2004;30(Pt 2):1546-9.
80. Xin H, Matt D, Qin JZ, et al. The sebaceous nevus: a nevus with deletions of the PTCH gene. Cancer Res 1999;59:1834-6.